Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

GLP-1 medications in Florida (2026)

Coverage, telehealth, compounding, and platform availability

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
Last verified by glpzoom Editorial Team against primary sources
0.0%
Florida adult obesity rate
Not covered
Florida Medicaid weight-loss coverage
Permitted
Interstate telehealth
Varies
Compounding 2026

Florida Medicaid and insurance coverage

Florida Medicaid does not cover GLP-1s for weight loss. Diabetes coverage available with prior authorization.

Commercial insurance coverage of GLP-1s in Florida typically requires prior authorization. Most plans cover Ozempic and Mounjaro for documented type 2 diabetes (the easier coverage path). Wegovy and Zepbound for weight loss require BMI documentation, often ≥30 with comorbidity. Use our insurance coverage tool to check your specific plan.

Telehealth prescribing in Florida

Florida is part of the Interstate Medical Licensure Compact; telehealth is widely permitted with state-licensed clinicians.

Top US telehealth platforms with active Florida availability: Hims Weight Loss, Ro Body, Sequence. Each handles insurance and prescribing differently — see our platform comparisons for details on which fits Florida patients best.

Compounding pharmacy status (2026)

Florida has historically been a high-volume compounded GLP-1 market; FDA 2026 enforcement has reduced availability significantly.

The national context: FDA proposed permanently ending 503B bulk compounding of semaglutide and tirzepatide on April 30, 2026, with a public comment period through June 29. Most state pharmacy boards are aligning enforcement. Patients currently on compounded GLP-1s in Florida should plan transition to branded direct-pay or insurance-covered options. See our guide on the compounding shutdown.

GLP-1 in Florida — frequently asked

Does Florida Medicaid cover Wegovy or Zepbound for weight loss?+

Not covered. Florida Medicaid does not cover GLP-1s for weight loss. Diabetes coverage available with prior authorization. Confirm coverage with your specific plan's formulary before assuming approval. For commercial insurance in Florida, coverage typically requires prior authorization with BMI documentation.

Can I get Wegovy or Ozempic via telehealth in Florida?+

Permitted. Florida is part of the Interstate Medical Licensure Compact; telehealth is widely permitted with state-licensed clinicians. Most major US telehealth platforms — including Hims Weight Loss, Ro Body, Sequence — operate in Florida with state-licensed clinicians.

Is compounded semaglutide still legal in Florida?+

Varies. Florida has historically been a high-volume compounded GLP-1 market; FDA 2026 enforcement has reduced availability significantly. The FDA proposed permanently ending 503B bulk compounding of semaglutide and tirzepatide on April 30, 2026. State boards of pharmacy implement enforcement at varying paces.

Which telehealth platforms operate in Florida?+

Major platforms with broad Florida availability include Hims Weight Loss, Ro Body, Sequence. Coverage by program varies — some prescribe branded Wegovy and Zepbound only, others bundle telehealth with compounded preparations where still permitted.

What's the cheapest way to get Wegovy in Florida?+

Three main paths: (1) insurance with prior authorization if your plan covers Wegovy (likely $0-$25 copay), (2) NovoCare manufacturer self-pay at $499/month for eligible cash patients, (3) telehealth programs that may bundle branded Wegovy with clinical visits. Direct-to-consumer manufacturer programs typically beat retail pharmacy prices.

Related

We may earn a commission when you click links to partners. Affiliate disclosure.